Pharmanovia Bidco Limited
Activities of other holding companies n.e.c. · Basildon
ActiveUnited KingdomIncorporated 2019Private Limited Company
Financial position
Accounts to 2026-03-31 · EUR · Company accounts
Net assets
−EUR 274,569,000
Cash
EUR 337,000
Turnover
—
Profit / loss
−EUR 261,978,000
Current assets
EUR 708,867,000
Creditors < 1 year
EUR 76,899,000
Equity
−EUR 274,569,000
Average employees
7
Balance-sheet trend
EUR · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2026-03-31Company · AI-read | 2025-03-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | −EUR 274,569,000 | −EUR 12,591,000 |
| Equity | −EUR 274,569,000 | −EUR 12,591,000 |
| Retained earnings | −EUR 607,669,000 | −EUR 345,691,000 |
| Assets | ||
| Fixed assets | EUR 73,808,000 | EUR 321,222,000 |
| Investments | EUR 73,808,000 | EUR 321,222,000 |
| Current assets | EUR 708,867,000 | EUR 758,618,000 |
| Cash at bank | EUR 337,000 | EUR 278,000 |
| Liabilities | ||
| Creditors within one year | EUR 76,899,000 | EUR 38,880,000 |
| Creditors after one year | EUR 979,317,000 | EUR 1,053,219,000 |
| Provisions | EUR 1,028,000 | EUR 332,000 |
| Net current assets | EUR 630,940,000 | EUR 719,406,000 |
| Assets less current liabilities | EUR 704,748,000 | EUR 1,040,628,000 |
| Profit & loss | ||
| Gross profit | EUR 7,319,000 | EUR 3,762,000 |
| Administrative expenses | EUR 11,434,000 | EUR 6,328,000 |
| Other operating income | EUR 7,319,000 | EUR 3,762,000 |
| Operating profit | −EUR 251,529,000 | −EUR 353,445,000 |
| Interest receivable | EUR 33,227,000 | EUR 32,046,000 |
| Interest payable | EUR 75,229,000 | EUR 97,317,000 |
| Profit before tax | −EUR 261,978,000 | −EUR 418,716,000 |
| Profit / loss | −EUR 261,978,000 | −EUR 418,716,000 |
| People & pay | ||
| Average employees | 7 | 8 |
| Staff costs | EUR 7,319,000 | EUR 3,762,000 |
| Wages & salaries | EUR 6,183,000 | EUR 3,156,000 |
| Social security costs | EUR 1,011,000 | EUR 481,000 |
| Pension costs | EUR 125,000 | EUR 125,000 |
| Directors' remuneration | EUR 2,721,000 | EUR 1,183,000 |
| Highest paid director | EUR 1,319,000 | EUR 535,000 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2026-03-31 say about themselves, read by AI from the scanned filing.
- Auditor
- S&W Audit
- Audit opinion
- Clean (unmodified)
- Immediate parent
- Pharmanovia Midco Limited
- Ultimate parent
- Triton Managers V Limited
- Accounts
- FRS 101
- Approved
- 2026-07-24, signed by J Owen
Related parties (16)
- Blenheim Capital Limited · Management recharges · 98 (000s)
- Blenheim Capital Limited · Management recharges · 93 (000s)
- Waymade Capital Limited · Management recharges · 148 (000s)
- Waymade Capital Limited · Management recharges · 300 (000s)
- Abra Midco SARL · Interest income · - (000s)
- Abra Midco SARL · Interest income · 176 (000s)
- Corporate and Accelerator Solutions Limited · Management recharges · 634 (000s)
- Corporate and Accelerator Solutions Limited · Management recharges · 680 (000s)
- Blenheim Capital Limited · Trade creditors · - (000s)
- Blenheim Capital Limited · Trade creditors · - (000s)
- Waymade Capital Limited · Trade creditors · 91 (000s)
- Waymade Capital Limited · Trade creditors · 86 (000s)
- Abra Midco SARL · Loans receivable · 1,353 (000s)
- Abra Midco SARL · Loans receivable · 1,276 (000s)
- Corporate and Accelerator Solutions Limited · Trade creditors · 174 (000s)
- Corporate and Accelerator Solutions Limited · Trade creditors · 261 (000s)
Borrowings (5)
- TLB syndication loan · 890,082 (000s) · Repayment in full on maturity; 2030
- Amounts owed to intercompany · 90,920 (000s) · Repayment in full on maturity; 2030
- Loan interest · 5,126 (000s) · Repayable quarterly
- Revolving credit facility · 33,315 (000s) · Repayment in full on maturity; 2030
- Intercompany revolving credit facility · 34,800 (000s) · Repayment in full on maturity; 2030
Share classes (1)
- 400 Ordinary of €0.01
Events after the year end (1)
- After the year end, the company drew down a further €26,000k from the revolving credit facility; the facility balance at signing was €61,000k.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
7 outstanding chargesAll Assets · created 2024-07-04
—
OutstandingAll Assets · created 2021-03-05
—
OutstandingFixed · created 2021-03-05
—
OutstandingFixed · created 2020-03-20
—
OutstandingAll Assets · created 2020-02-26
—
OutstandingFixed · created 2019-09-03
—
OutstandingAll Assets · created 2019-07-26
—
Outstanding